Tissue Repair
Tony Charara is a seasoned entrepreneur and executive with extensive experience in the healthtech and biopharmaceutical sectors. As Co-Founder and CEO of Mable, Tony leads Australia’s premier platform connecting care professionals with consumers in need of health services and aged care. Additionally, as Co-Founder and Executive Director of Tissue Repair, Tony plays a pivotal role in developing innovative drugs aimed at enhancing wound healing, with the company set to enter phase III trials in 2023. Tony also serves as Principal at Spark Capital, a specialist corporate advisory and venture firm. Tony holds a Bachelor of Commerce with Honours in Finance from the University of Sydney.
This person is not in any teams
Tissue Repair
Tissue Repair Ltd is an Australian biopharmaceutical company developing an advanced wound healing technology targeting applications in the chronic wound and cosmetic procedure markets. Tissue Repair has developed a unique active ingredient that is designed for wound healing and delivered topically. The biologically active pharmaceutical ingredient behaves like a decoy cell and simulates a yeast infection resulting in the stimulation of the body’s own wound repair pathways. This active ingredient also provides a platform for the opportunity to develop a range of products that have the potential to treat a broad range of conditions across the wound care market.